We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Arterial Gas Analyzer and Autoanalyzer Compared for Electrolytes

By LabMedica International staff writers
Posted on 28 Mar 2013
Print article
Electrolyte values are measured in most critically ill intensive care unit (ICU) patients using both an arterial blood gas analyzer (ABG) and a central laboratory autoanalyzer (AA).

Data on sodium and potassium ion concentrations in ICU patients have been examined to see whether the electrolyte levels assessed by the ABG and the AA are equivalent and reliable.

Scientists at the Sevket Yilmaz Education and Research Hospital (Bursa, Turkey) retrospectively studied patients hospitalized in the ICU between July and August 2011. They identified 84 instances, of 1,105 patient blood gas samples analyzed, in which arterial and venous samples were collected simultaneously and sodium (Na+) and (K+) were measured using two methods.

In the ICU, arterial blood samples were collected in heparinized blood-gas syringes and analyzed using the benchtop pHOx Stat Profile Plus L blood–gas analyzer (Nova Biomedical; Waltham MA, USA) which employs direct ion-specific electrode (ISE) technology. Another sample was drawn, at the same time, from the same arterial sampling point, using a vacuum technique featuring clot-activating tubes. These samples were sent, pneumatically sealed, to the central laboratory, where serum Na+ and K+ concentrations were analyzed via indirect ISE on a Modular ISE900 auto-analyzer (Roche Diagnostics; Mannheim, Germany).

The mean sodium concentration was 138.mmol/L (standard deviation, SD ±10.2 mmol/L) using the ABG and 143.0 mmol/L (SD ±10.5 mmol/L) using the AA, which was statistically different. The mean potassium level was 3.5mmol/L (SD ± 0.9 mmol/L) using the ABG and 3.7 mmol/L (SD ± 1.0 mmol/L) using the AA which was also significantly different. The extent of interanalyzer agreement was unacceptable for both K+ and Na+. The between-day imprecision of both instruments (AA and ABG) was small and lacked clinical significance when compared with analytical performance indicators based on biological variation.

The authors concluded that their study illustrates the importance of determining the concordance, for each individual hospital, of electrolyte values obtained by ABG and those obtained in the central laboratory. As instrument type and calibration methods may differ among hospitals, it is important that each center conducts an in-house study as in their study the ABG and AA do not yield equivalent Na+ and K+ data. The study was published on August 3, 2012, in the BioMed Central journal BMC Anesthesiology.

Related Links:

Sevket Yilmaz Education and Research Hospital
Nova Biomedical
Roche



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Uric Acid and Blood Glucose Meter
URIT-10

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.